Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Jeremy_Levin
|
| gptkbp:collaboratedWith |
gptkb:Takeda_Pharmaceutical_Company
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:developedBy |
gptkb:OV101
gptkb:OV935 |
| gptkbp:focusesOn |
gptkb:Dravet_syndrome
gptkb:Angelman_syndrome epilepsy rare neurological disorders |
| gptkbp:foundedIn |
2014
|
| gptkbp:founder |
gptkb:Jeremy_Levin
|
| gptkbp:headquartersLocation |
gptkb:New_York_City
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:publiclyTraded |
yes
|
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:stockSymbol |
OVID
|
| gptkbp:website |
https://www.ovidrx.com/
|
| gptkbp:bfsParent |
gptkb:John_Maraganore
|
| gptkbp:bfsLayer |
6
|
| https://www.w3.org/2000/01/rdf-schema#label |
Ovid Therapeutics
|